Press release
RNA Therapeutics Market Share Set To Grow with Significant 5.6% CAGR By 2028
Cardiac Safety Services Market
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235963408&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Browse in-depth TOC on "RNA Therapeutics Market"
135 - Tables
36 - Figures
171 - Pages
Key Market Players Of RNA Therapeutics Industry :
The prominent players in the global RNA therapeutics market include Moderna, Inc. (US), Alnylam Pharmaceuticals, Inc. (US), Pfizer Inc. (US), Novartis AG (Switzerland), Ionis Pharmaceuticals, Inc. (US), Sarepta Therapeutics, Inc. (US), Sanofi (France), Arrowhead Pharmaceuticals, Inc. (US), BioNtech SE (Germany), Orna Therapeutics (US), CRISPR Therapeutics (Switzerland), Silence Therapeutics (UK), Astellas Pharma Inc. (Japan), CureVac SE (Germany), Sirnaomics (US), Arcturus Therapeutics Inc. (US) and Arbutus Biopharma (US).
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235963408&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
RNA Therapeutics Market Dynamics:
Drivers:
1. Increasing partnerships and collaborations among market players and RNA technology manufacturers
Restraints:
1. Discontinuation or recalls of RNA therapeutic products
Opportunities:
1. Higher progress in the development of RNA aptamer-based therapeutics
Challenge:
1. Rapid degradation by ubiquitous RNases in environment and tissues with strong immunogenicity of exogenous RNA
This research report categorizes the RNA therapeutics market to forecast revenue and analyze trends in each of the following submarkets:
By Product
• Vaccines
• Drugs
By Type
• mRNA Therapeutics
• RNA Interference (RNAi) Therapeutics
• Antisense Oligonucleotide (ASO) Therapeutics
• Other Therapeutics
By Indication
• Infectious Diseases
• Rare Genetic Diseases/Hereditary Diseases
• Other Indications
By End User
• Hospitals and Clinics
• Research Settings
By Region
• North America
• Europe
• Asia Pacific
• South Korea
• Rest of the World
Recent Developments of RNA Therapeutics Industry
• In February 2023, Moderna, Inc. received authorization from Health Canada for its COVID-19 booster vaccine, mRNA-1273.214 (SpikevaxBivalent Original/Omicron). This vaccine is designed for immunization against COVID-19 in children and adolescents between 6 to 17 years.
• In January 2023, the US FDA granted Breakthrough Therapy Designation for Moderna's investigational mRNA vaccine candidate-mRNA-1345. This vaccine was developed to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) in adults aged 60 years or older.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=235963408&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Therapeutics Market Share Set To Grow with Significant 5.6% CAGR By 2028 here
News-ID: 3380645 • Views: …
More Releases from MarketsandMarkets
Electric Scooter and Motorcycle Market Size, Share, Trends & Forecast by 2028
The global electric scooter and motorcycle market worldwide size was valued at USD 4.9 billion in 2023 and is expected to reach USD 14.7 billion by 2028, at a CAGR of 24.8% from 2023 to 2028. With rising emission levels, increasing prices, and the limited availability of petroleum, the demand for zero-emission alternative fuel vehicles has increased. This has, in turn, increased the demand for electric two-wheelers during the last…
North America FOG Market worth $25.6 billion by 2044 | Key players Downey Ridge …
According to recent market research the "North America FOG Market by Type (Brown & Yellow grease), Generation (Restaurants/fast food restaurants, Food Processing Facility, Water Treatment Facility), Application, and Country (US, Canada, Mexico) - Global Forecast to 2044", size is projected to grow from USD 9.5 billion in 2022 to USD 25.6 billion by 2044, at a CAGR of 4.6% during the forecast period. The growth of this market is attributed…
Recycled PET Market worth $15.0 billion by 2028 | Key players Biffa (UK), Far Ea …
According to recent market research the "Recycled PET Market by Type (Flakes, Chips), Grade (Grade A, Grade B), Source (Bottles & Containers, Films & sheets), Application ( Bottles, fiber, Sheets, Strapping), Color (Clear, Coloured), & Region (APAC, NA, Europe, MEA, SA) - Global Forecast to 2028", The global recycled PET market size is projected to reach USD 15.0 billion by 2028, at a CAGR of 6.5% from 2023 to 2028.…
Dental 3D Printing Market worth $8.1 billion in 2029
Dental 3D Printing Market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $8.1 billion by 2029, growing at a CAGR of 19.0% from 2023 to 2029 according to a new report by MarketsandMarkets™. 3D printing boasts exceptional precision, capturing intricate details and smooth surfaces, ideal for prosthetics, crowns, and intricate dental models. This translates to superior fit, aesthetics, and functionality…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
